4.5 Review

Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment

Journal

NEUROLOGICAL SCIENCES
Volume 42, Issue 7, Pages 2653-2660

Publisher

SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10072-021-05234-x

Keywords

Nanoparticles; Neurodegenerative diseases

Ask authors/readers for more resources

The World Health Organization has declared neurodegenerative diseases as the biggest health issues of the 21st century, with Alzheimer's and Parkinson's diseases being considered the most acute incurable neurological diseases. Researchers are studying and developing new treatment approaches using nanotechnology to reverse these diseases, aiming to regress nerve cells apoptosis, reduce inflammation, and improve drug delivery to the brain.
The World Health Organization (WHO) has declared that neurodegenerative diseases will be the biggest health issues of the twenty-first century. Among these, Alzheimer's and Parkinson's diseases can be considered as the most acute incurable neurological diseases. Researchers are studying and developing a new treatment approach that uses nanotechnology to diagnosis and treatment neurodegenerative diseases. This treatment strategy will be used to regress neurodegenerative diseases such as Alzheimer's disease. Alzheimer's disease (AD) is one of the most common forms of reduced brain function, which causes many devastating complications. Current neurodegenerative diseases treatment protocols only help to treat symptoms nevertheless with nanotechnology approaches, can regress nerve cells apoptosis, reduce inflammation, and improve brain drug delivery. In this paper, new nanotechnology methods such as nanobodies, nano-antibodies, and lipid nanoparticles have been investigated. Correspondingly blood-brain barrier drug delivery improvement methods have been suggested.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available